More Big(ger) Pharma
This week, Pfizer (#163 of the Global 5000 list) announced it was acquiring King Pharmaceuticals (#2441 on our list). This will add another $1.7 billion of revenue to Pfizer and move them up a few notches on our list. As always, those who sell products and services to King will now have to monitor the […]